The bill would change Medicare payment rules for certain colorectal cancer screening tests. It sets Medicare’s payment share at 100 percent for each subsequent year and removes the current end date stated in the law.
If enacted, people with Medicare would not have to pay coinsurance for the covered screening tests. The bill is limited to certain tests; it does not list them here.
The bill does not provide estimates of federal spending or savings. It would eliminate patient coinsurance for the covered tests.
No publicly available information.
No publicly available information.